IPP Bureau

Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey
Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey

By IPP Bureau - June 11, 2026

Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials

Evonik unveils probiotic advance in fight against antibiotic resistance
Evonik unveils probiotic advance in fight against antibiotic resistance

By IPP Bureau - June 11, 2026

Evonik researchers say they have achieved a significant breakthrough with Ecobiol

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager

By IPP Bureau - June 11, 2026

Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions

Glenmark launches Winlevi across key European markets
Glenmark launches Winlevi across key European markets

By IPP Bureau - June 11, 2026

First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe

ASMS explores strategic research collaboration with Mediciti Institute
ASMS explores strategic research collaboration with Mediciti Institute

By IPP Bureau - June 11, 2026

Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings

Cloudnine Hospitals launches one-year fellowship for obstetricians and gynaecologists
Cloudnine Hospitals launches one-year fellowship for obstetricians and gynaecologists

By IPP Bureau - June 11, 2026

Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine

Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies

By IPP Bureau - June 11, 2026

The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy

Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound
Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound

By IPP Bureau - June 11, 2026

The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed

Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access

By IPP Bureau - June 11, 2026

The Prayagraj lab is designed to handle both routine and specialised testing

DFE Pharma wins third straight EcoVadis Gold Medal
DFE Pharma wins third straight EcoVadis Gold Medal

By IPP Bureau - June 11, 2026

The award places the company in the top 5% globally

Dr. Alka Rao becomes first woman director of CSIR-IMTECH
Dr. Alka Rao becomes first woman director of CSIR-IMTECH

By IPP Bureau - June 11, 2026

Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI

Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect
Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect

By IPP Bureau - June 11, 2026

Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

By IPP Bureau - June 11, 2026

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

By IPP Bureau - June 11, 2026

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

By IPP Bureau - June 11, 2026

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer

Latest Stories

Interviews

Packaging